Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor α and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules

Arthritis and Rheumatism

Volumn 43, Issue 5, 2000, Pages 1106-1114

  Kobayashi, Tetsuya ^a   Okamoto, Kazuyoshi ^a   Kobata, Tetsuji ^a,b   Hasunuma, Tomoko ^a   Kato, Tomohiro ^a   Hamada, Hirofumi ^c   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CASPASE 3; CASPASE 8; FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; ANTIGENS, SURFACE; APOPTOSIS; ARTHRITIS, RHEUMATOID; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASE 9; CASPASES; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN SORTING SIGNALS; PROTO-ONCOGENE PROTEINS C-BCL-2; SYNOVIAL MEMBRANE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034083131     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200005)43:5<1106::AID-ANR21>3.0.CO;2-F     Document Type: Article

References (36)

1. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Nishioka K, Hasunuma T, Kato T, Sumida T, Kobata T. Apoptosis in rheumatoid arthritis: a novel pathway in the regulation of synovial tissue. Arthritis Rheum 1998;41:1-9.
3. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485-91.
4. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
5. Asahara H, Hasunuma T, Kobata T, Yagita H, Okumura K, Inoue H, et al. Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. Clin Immunol Immunopathol 1996;81: 27-34.
6. Hasunuma T, Hoa TTM, Aono H, Asahara H, Yonehara S, Yamamoto K, et al. Induction of Fas-dependent apoptosis in synovial infiltrating cells in rheumatoid arthritis. Int Immunol 1996;8:1595-602.
7. Okamoto K, Fujisawa K, Hasunuma T, Kobata T, Sumida T, Nishioka K. Selective activation of the JNK/AP-1 pathway in Fas-mediated apoptosis of rheumatoid arthritis synoviocytes. Arthritis Rheum 1997;40:919-26.
8. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Sumida T, Nishioka K. Tumor necrosis factor α regulation of the Fas-mediated apoptosis-signaling pathway in synovial cells. Arthritis Rheum 1999;42:519-26.
9. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-400.
10. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9.
11. Gitter BD, Labus JM, Lees SL, Scheetz ME. Characteristics of human synovial fibroblast activation by IL-1β and TNFα. Immunology 1989;66:196-200.
12. Melnyk VO, Shipley GD, Sternfeld MD, Sherman L, Rosenbaum JT. Synoviocytes synthesize, bind, and respond to basic fibroblast growth factor. Arthritis Rheum 1990;33:493-500.
13. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1977;388:190-5.
14. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 1997;272:17255-7.
15. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D. CASH, a novel caspase homologue with death effector domains. J Biol Chem 1997;272:19641-4.
16. Inohara N, Koseki T, Hu Y, Chen S, Núñez G. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc Natl Acad Sci U S A 1997;94:10717-22.
17. Shu HB, Halpin DR, Goeddel DV. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 1997;6:751-63.
18. Srinivasula SM, Ahmad M, Ottilie S, Bullrich F, Banks S, Wang Y. et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem 1997;272: 18542-5.
19. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K. Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor α. Arthritis Rheum 1996;39:197-203.
20. Shinoura N, Yoshida Y, Sadata A, Hamada K, Yamamoto S, Kirino T, et al. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy. Hum Gene Ther 1998;9:1983-93.
21. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT-1/FADD-interacting protease, in Fas/ APO-1- and TNF receptor-induced cell death. Cell 1996;85:803-15.
22. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevehenko A, Ni J, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817-27.
23. Qu Z, Huang XN, Ahmadi P, Andresevic J, Planck SR, Hart CE, et al. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995;73:339-46.
24. Qu Z, Picou M, Dang TT, Angell E, Planck SR, Hart CE, et al. Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvant arthritis in the Lewis rats. Am J Pathol 1994;145:1127-39.
25. Anderson GP. Bcl-2 related proteins, apoptosis and disease. Trends Pharmacol Sci 1997;18:51.
26. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-6.
27. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
28. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. 1A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995;270:7795-8.
29. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-12.
30. Okamoto K, Kobayashi T, Kobota T, Hasunuma T, Kato T, Sumida T, et al. FADD is a Fas-mediated apoptosis modulator in synoviocytes. Rheumatology. In press.
31. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, et al. FLICE is activated by association with the C95 death-inducing signaling complex (DISC). EMBO J 1997;16:2794-804.
32. Refaeli Y, van Parijs L, London CA, Tshopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998;8:615-23.
33. Kataoka T, Schršer M, Hahne M, Schneider P, Irmler M, Thome M, et al. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J Immunol 1998;161:3936-42.
34. Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD-95-induced apoptosis. J Biol Chem 1999;274: 1541-8.
35. O'Sullivan JB, Cathcart ES. The prevalence of rheumatoid arthritis: follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med 1972;76:573-7.
36. Feigenbaum S, Masi AT, Kaplan SB. Prognosis in rheumatoid arthritis: a longitudinal study of newly diagnosed younger adult patients. Am J Med 1979;66:377-84.